ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Granite Investment Partners LLC

Granite Investment Partners LLC reduced its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 2.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 102,087 shares of the medical instruments supplier’s stock after selling 2,215 shares during the quarter. Granite Investment Partners LLC’s holdings in ICU Medical were worth $15,841,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Arizona State Retirement System increased its position in shares of ICU Medical by 1.0% during the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier’s stock worth $1,044,000 after purchasing an additional 65 shares in the last quarter. Huntington National Bank increased its position in ICU Medical by 6.2% during the fourth quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier’s stock worth $218,000 after buying an additional 82 shares during the period. Equitable Trust Co. lifted its stake in ICU Medical by 1.6% in the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock valued at $822,000 after buying an additional 84 shares during the last quarter. LPL Financial LLC boosted its holdings in shares of ICU Medical by 2.0% in the fourth quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier’s stock valued at $747,000 after acquiring an additional 93 shares during the period. Finally, Alliancebernstein L.P. grew its position in shares of ICU Medical by 0.5% during the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier’s stock worth $4,051,000 after acquiring an additional 136 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Raymond James set a $97.00 price target on shares of ICU Medical in a research report on Wednesday, March 12th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Friday, April 4th. Finally, Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Tuesday, April 8th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, ICU Medical has a consensus rating of “Buy” and a consensus price target of $168.67.

ICU Medical Stock Performance

Shares of ICUI opened at $142.65 on Friday. The stock has a market capitalization of $3.50 billion, a P/E ratio of -31.21 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The company’s fifty day moving average is $148.29 and its two-hundred day moving average is $160.95.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.